01:34 PM EDT, 05/15/2024 (MT Newswires) -- Yield10 Bioscience ( YTEN ) said Wednesday it received a final delisting notice from Nasdaq after failing to regain compliance with the exchange's listing rule that requires listed firms to maintain stockholder's equity of at least $2.5 million.

Shares slumped 38% with intraday volume topping 304,000 shares versus the daily average of about 172,000.

Bolt Biotherapeutics ( BOLT ) shares fell 34%, a day after the company said it plans to stop the development of trastuzumab imbotolimod, BDC-1001, and the workforce will be cut by 50%.

Volume topped 2.85 million versus the daily average of about 137,000.

Aethlon Medical ( AEMD ) said Wednesday it priced an offering of 8.1 million shares and related class A and B warrants at a combined public offering price of $0.58 a share for proceeds of $4.7 million.

The shares slumped 47% as volume topped 6.09 million versus the daily average of almost 396,000.

Price: 3.26, Change: -2.00, Percent Change: -38.04